TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure July 5, 1991
TCL Archive FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005. July 3, 2008